Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2014 1
2016 3
2017 3
2018 6
2019 8
2020 10
2021 12
2022 10
2023 13
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Cerebrotendinous xanthomatosis revisited.
Baghbanian SM, Mahdavi Amiri MR, Majidi H. Baghbanian SM, et al. Pract Neurol. 2021 Jun;21(3):243-245. doi: 10.1136/practneurol-2020-002895. Epub 2021 Apr 14. Pract Neurol. 2021. PMID: 33853856
Neuromyelitis optica and pregnancy.
Zare-Shahabadi A, Langroodi HG, Azimi AR, Sahraian MA, Harirchian MH, Baghbanian SM. Zare-Shahabadi A, et al. Among authors: baghbanian sm. Acta Neurol Belg. 2016 Dec;116(4):431-438. doi: 10.1007/s13760-016-0654-x. Epub 2016 Jun 15. Acta Neurol Belg. 2016. PMID: 27306993 Review.
Disaster and Multiple Sclerosis: A Systematic Review.
HabibiSaravi R, Baghbanian SM, Navaie R, Sayfouri N, Seyedin H, Gohardehi F, Ghasemihamedani F. HabibiSaravi R, et al. Among authors: baghbanian sm. Iran J Public Health. 2022 Sep;51(9):1936-1949. doi: 10.18502/ijph.v51i9.10549. Iran J Public Health. 2022. PMID: 36743361 Free PMC article. Review.
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.
Yeh WZ, Van Der Walt A, Skibina OG, Kalincik T, Alroughani R, Kermode AG, Fabis-Pedrini MJ, Carroll WM, Lechner-Scott J, Boz C, Ozakbas S, Buzzard K, Habek M, John NA, Prat A, Girard M, Duquette P, Baghbanian SM, Hodgkinson S, Van Pesch V, Laureys G, Willekens B, Prevost J, Foschi M, De Gans K, Horakova D, Havrdova EK, Karabudak R, Patti F, Mccombe PA, Maimone D, Altintas A, Ampapa R, Spitaleri D, Gerlach OHH, Sa MJ, Hughes S, Gouider R, Mrabet S, Macdonell RA, Turkoglu R, Cartechini E, Al-Asmi A, Soysal A, Oh J, Muros-Le Rouzic E, Guye S, Pasquarelli N, Butzkueven H, Jokubaitis VG; MSBase Study Group. Yeh WZ, et al. Among authors: baghbanian sm. Neurol Neuroimmunol Neuroinflamm. 2024 Nov;11(6):e200328. doi: 10.1212/NXI.0000000000200328. Epub 2024 Oct 23. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39442037 Free PMC article.
Primary progressive multiple sclerosis in Iran: A consensus recommendation for diagnosis and management.
Sahraian MA, Baghbanian SM, Langroodi HG, Abolfazli R, Alaie S, Asgari N, Ashtari F, Ayromlouh H, Moghadam NB, Foroughipour M, Majdinasab N, Mohammadianinejad SE, Nickseresht A, Nourian A, Shahmohammadi S, Shayegannejad V, Torabi HR. Sahraian MA, et al. Among authors: baghbanian sm. Mult Scler Relat Disord. 2018 Nov;26:112-120. doi: 10.1016/j.msard.2018.09.013. Epub 2018 Sep 12. Mult Scler Relat Disord. 2018. PMID: 30245383 Review. No abstract available.
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic.
Lal AP, Foong YC, Sanfilippo PG, Spelman T, Rath L, Levitz D, Fabis-Pedrini M, Foschi M, Habek M, Kalincik T, Roos I, Lechner-Scott J, John N, Soysal A, D'Amico E, Gouider R, Mrabet S, Gross-Paju K, Cárdenas-Robledo S, Moghadasi AN, Sa MJ, Gray O, Oh J, Reddel S, Ramanathan S, Al-Harbi T, Altintas A, Hardy TA, Ozakbas S, Alroughani R, Kermode AG, Surcinelli A, Laureys G, Eichau S, Prat A, Girard M, Duquette P, Hodgkinson S, Ramo-Tello C, Maimone D, McCombe P, Spitaleri D, Sanchez-Menoyo JL, Yetkin MF, Baghbanian SM, Karabudak R, Al-Asmi A, Jakob GB, Khoury SJ, Etemadifar M, van Pesch V, Buzzard K, Taylor B, Butzkueven H, Van der Walt A. Lal AP, et al. Among authors: baghbanian sm. J Neurol. 2024 Sep;271(9):5813-5824. doi: 10.1007/s00415-024-12518-7. Epub 2024 Jun 27. J Neurol. 2024. PMID: 38935148 Free PMC article.
Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial.
Sahraian MA, Abolfazli R, Shaygannejad V, Ashtari F, Majdinasab N, Navardi S, Baghbanian SM, Sedighi B, Naser Moghadasi A, Nahayati MA, Ghalyanchi Langroodi H, Mohammadianinejad SE, Beladi Moghadam N, Ayromlou H, Nikseresht A, Ghiasian M, Razazian N, Asadollahzadeh E, Sabzvari A, Kafi H, Albooyeh S. Sahraian MA, et al. Among authors: baghbanian sm. Sci Rep. 2024 Oct 22;14(1):24921. doi: 10.1038/s41598-024-75745-y. Sci Rep. 2024. PMID: 39438591 Free PMC article. Clinical Trial.
Management of seizures in patients with multiple sclerosis; an Iranian consensus.
Asadi-Pooya AA, Sahraian MA, Sina F, Baghbanian SM, Habibabadi JM, Shaygannejad V, Asadollahi M, Karvigh SA, Moghadasi AN, Nikseresht A, Motamedi M. Asadi-Pooya AA, et al. Among authors: baghbanian sm. Epilepsy Behav. 2019 Jul;96:244-248. doi: 10.1016/j.yebeh.2019.04.032. Epilepsy Behav. 2019. PMID: 31151870 Review.
62 results